Earnings ·
Senseonics Holdings reported second quarter 2026 revenue of $14.5 million, a 120% year-over-year increase, driven by…
SENSSenseonics Holdings, Inc.
Senseonics Holdings reported second quarter 2026 revenue of $14.5 million, a 120% year-over-year increase, driven by U.S. sales growth exceeding 150%. The company raised its full-year 2026 revenue guidance to $62–$66 million and gross margin guidance to 58–61%, citing strong commercial momentum and the integration of European operations. Q2 net loss widened to $36.7 million ($0.63 per share) from $14.5 million in the prior year, primarily due to increased R&D expenses for Gemini and Freedom programs and SG&A costs related to commercial integration. Senseonics raised more than $100 million in Q2 through equity proceeds and an expanded Hercules Capital facility, ending the quarter with $143.0 million in cash and equivalents. The company operates in the medical technology industry, designing and commercializing implantable continuous glucose monitoring systems for diabetes management.